Allogene Therapeutics (ALLO) Receivables - Net (2020)
Allogene Therapeutics (ALLO) has disclosed Receivables - Net for 1 consecutive years, with $3.1 million as the latest value for Q3 2020.
Allogene Therapeutics (ALLO) has disclosed Receivables - Net for 1 consecutive years, with $3.1 million as the latest value for Q3 2020.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month